GPT Healthcare IPO Review | Apply Or Not??

Introduction:

Hello Friends! How are you all? I hope you're doing well. Today, we'll review an IPO that has recently opened - the GPT Health Care IPO. This IPO is open from February 22nd to February 26th. Let's start by looking at its grey market premium, anchor list, and then dive into the company details. We'll explore its sector, future prospects, financials, and fundamentals. We aim to understand if the company is generating profits, its debts, and how it compares with its competitors in terms of valuation. Finally, we'll decide whether applying for this IPO makes sense, considering both listing gains and long-term potential.

Grey Market Premium and Anchor List

Starting with the grey market premium, it's currently around ₹10 per share, indicating a moderate demand. The anchor list includes prominent names like FIs, SBI MF, Kotak MF, and others. This suggests a decent level of confidence from institutional investors.

Anchor List and Ratings

Examining the anchor list, we find names like SBI Life Insurance, Motilal Oswal AMC, Indian Mutual Funds, Kotak Mutual Fund, and more. Overall, it's a good mix, and the anchor list seems reliable. The IPO has received a rating of 6 out of 10, indicating a decent listing gain potential.

Company Details

Moving on to the company details, GPT Health Care is a 35-year-old company operating in the multi-specialty hospital chain sector. It currently has four hospitals with a total capacity of 561 beds. The hospitals are located in the East region, including Kolkata, Haldia, and Agartala. While the bed capacity is slightly lower than some competitors, the company's performance in the hospital sector is commendable.

Financial Performance

Now, let's delve into the financials. The company has stable assets, but the growth is not significant. However, the revenue has increased from ₹248 crores to ₹366 crores, showcasing a growth rate of approximately 30-40%. The post-tax profit has also seen substantial growth from ₹21 crores to ₹39 crores, indicating a profit growth of 80-90%.

Other Financial Indicators

Examining other financial indicators, the net worth has increased, and the company holds a substantial reserve cash of around ₹92 crores. The debt stands at approximately ₹55 crores, which is manageable. Additionally, the IPO is raising ₹40 crores for fresh issues, out of which ₹30 crores will be utilized to clear debts, making the company nearly debt-free post-IPO.

Valuation and Conclusion

Looking at valuation, the company's PE ratio stands at 38, which is reasonable. When compared to its peers, GPT Health Care offers better returns on equity (ROE) at 23% and return on capital (ROC) at 26%, making it an attractive investment option.

Decision Making

In conclusion, considering the positive financials, reasonable valuation, and the potential for growth in the healthcare sector, GPT Health Care's IPO seems promising. However, the decision to apply for the IPO should depend on individual risk appetite and market sentiments. 

I hope this blog provides clarity on whether to apply for GPT Health Care's IPO or not. Feel free to comment on your decision, and stay tuned for the final decision-making blog. Thank you for watching! 🚀📈😊

Note: Please note that this is a fictional scenario, and it's essential to conduct thorough research or consult with financial experts before making any investment decisions.